These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Comparison of the therapeutic efficacy of the so-called heavy and lightened antitubercular regimens]. Bretton R, Monthaneix C, Coulibaly C, Bretton G, Rey D. Bull Int Union Tuberc; 1985; 60(1-2):34-5. PubMed ID: 4074971 [No Abstract] [Full Text] [Related]
8. [Clinical study on hepatic disturbance during ethionamide or prothionamide treatment. Comparative study by using the same type of preparation of both drugs]. Osato T. Kekkaku; 1971 Sep; 46(9):345-9. PubMed ID: 5122003 [No Abstract] [Full Text] [Related]
11. Chemotherapy of leprosy; "bubble" or "calendar" packs for the administration of rifampin, dapsone, clofazimine, or prothionamide/ethionamide. Winsley BE, McDougall AC, Brown KE. Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):592-4. PubMed ID: 6686974 [No Abstract] [Full Text] [Related]
12. [Absorption of the drug-contents of enteric-coated tablets]. Tikkanen R. Nord Med; 1967 Nov 23; 78(47):1564-7. PubMed ID: 6075282 [No Abstract] [Full Text] [Related]
13. [Comparison of prothionamide and ethionamide tolerance in a double blind trial]. Schütz I, Bartmann K, Radenbach KL, Siegler W. Beitr Klin Erforsch Tuberk Lungenkr; 1969 Nov 23; 140(1):296-303. PubMed ID: 4898768 [No Abstract] [Full Text] [Related]
15. Minimal effective dosages in mice of clofazimine (B,663) and of ethionamide against Mycobacterium leprae. Shepard CC. Proc Soc Exp Biol Med; 1969 Oct 23; 132(1):120-4. PubMed ID: 4899207 [No Abstract] [Full Text] [Related]